Scholar Rock Holding (SRRK) Times Interest Earned (2024 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Times Interest Earned of -$44.32 in Q1 2026, down 22.2% quarter-over-quarter from -$36.27 in Q4 2025, and down 4.51% on a YoY basis from -$46.41 in Q1 2025.
Scholar Rock Holding (SRRK) Times Interest Earned (2024 - 2026) Analysis & Trends
Scholar Rock Holding's Times Interest Earned history runs 3 years deep, the most recent figure standing at -$44.32 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 4.51% year-over-year to -$44.32; the TTM figure through Mar 2026 stood at -$55.53 (down 42.0% YoY), while the FY2025 annual figure was -$55.8, down 51.36% from the prior year.
- Times Interest Earned was -$44.32 for Q1 2026 at Scholar Rock Holding, down from -$36.27 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$33.73 in Q1 2024 to a low of -$92.96 in Q2 2025.
- Historically, Times Interest Earned has averaged -$49.03 across 3 years, with a median of -$42.14 in 2024.
- Biggest YoY gain for Times Interest Earned was 13.93% in 2025; the steepest drop was 167.95% in 2025.
- A 3-year view of Times Interest Earned shows it stood at -$42.14 in 2024, then increased by 13.93% to -$36.27 in 2025, then slipped by 22.2% to -$44.32 in 2026.
- The last three Times Interest Earned figures came in at -$44.32 (Q1 2026), -$36.27 (Q4 2025), and -$77.62 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | -44.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.32 |
| Dec 31, 2025 | -36.27 |
| Sep 30, 2025 | -77.62 |
| Jun 30, 2025 | -92.96 |
| Mar 31, 2025 | -42.40 |
| Dec 31, 2024 | -42.14 |
| Sep 30, 2024 | -37.14 |
| Jun 30, 2024 | -34.69 |
| Mar 31, 2024 | -33.73 |